UBS Group set a €126.00 ($148.24) target price on Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) in a report released on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
Other analysts have also issued reports about the company. Nord/LB set a €110.00 ($129.41) target price on shares of Carl Zeiss Meditec AG (AFX.F) and gave the stock a buy rating in a report on Monday, August 10th. Kepler Capital Markets set a €80.00 ($94.12) target price on Carl Zeiss Meditec AG (AFX.F) and gave the company a sell rating in a research note on Friday, August 7th. Berenberg Bank set a €87.00 ($102.35) target price on Carl Zeiss Meditec AG (AFX.F) and gave the stock a neutral rating in a report on Wednesday, September 23rd. DZ Bank reaffirmed a sell rating on shares of Carl Zeiss Meditec AG (AFX.F) in a research note on Monday, August 10th. Finally, Deutsche Bank Aktiengesellschaft set a €110.00 ($129.41) price objective on shares of Carl Zeiss Meditec AG (AFX.F) and gave the stock a buy rating in a research note on Thursday, August 6th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of €102.25 ($120.29).
AFX stock opened at €118.70 ($139.65) on Friday. The company has a quick ratio of 3.05, a current ratio of 4.06 and a debt-to-equity ratio of 3.62. Carl Zeiss Meditec AG has a twelve month low of €67.70 ($79.65) and a twelve month high of €123.90 ($145.76). The company has a market cap of $10.62 billion and a P/E ratio of 88.91. The business has a fifty day moving average of €106.27 and a 200-day moving average of €94.56.
About Carl Zeiss Meditec AG (AFX.F)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Story: How Investors Use a Balance Sheet
Receive News & Ratings for Carl Zeiss Meditec AG (AFX.F) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG (AFX.F) and related companies with MarketBeat.com's FREE daily email newsletter.